drugset / Trial / NCT01076491

High Dose Inhaled Mannitol Study

NCT01076491

Phase 1/2 Completed 10 enrolled Syntara
RandomizedSingle-groupOpen-label

Summary

This study is to investigate the safety and tolerability of high doses of inhaled mannitol in subjects with bronchiectasis to further direct development of an improved drug delivery system.

Timeline

Start
2009-01
Primary completion
2009-03
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Mannitol Diagnostic / imaging agent 70 mg Inhaled
Subject Mannitol Diagnostic / imaging agent 90 mg Inhaled

Indications